October 21, 2009 – Carestream Health Inc. yesterday announced the availability of its new Web-based cardiology PACS that provides an efficient enterprise-wide image and information management solution for cardiology data. The CARESTREAM Cardiology PACS is now available in the United States, Canada, United Kingdom, Netherlands and Italy.

October 21, 2009 - GE Healthcare launched a new solution that puts clinical data and treatment practices in the hands of doctors and clinicians in real-time so that they can make informed decisions right at the point of care.

October 20, 2009 - Sen. Debbie Stabenow (D-Michigan), joined by representatives of the American Medical Association (AMA), American Association of Retired Persons (AARP) and the Military Officers Association of America at a Capitol Hill news conference, urged lawmakers to reverse $247 billion in projected Medicare reimbursement cuts to doctors.

October 20, 2009 – ScottCare Corp. this week released the Chroma Holter monitor, which the company says is the industry’s first full-color Holter monitor that more effectively addresses the needs of both the patient and the clinician.

October 19, 2009 – iMobileHealth yesterday launched the iAorticValve Web site and iPhone application to allow doctors and patients to access and use critical aortic valve information and have it at their fingertips in a mobile form.

October 19, 2009 – Boehringer Ingelheim Pharmaceuticals Inc.

October 19, 2009 – PLC Systems Inc. today said its RenalGuard System will be utilized as part of a live case transmission from the Clinica Mediterranea, Naples, Italy, to the 30th Congresso Nazionale della Societa' Italiana di Cardiologia Invasiva (GISE), Oct. 20-23, in Bologna, Italy.

October 16, 2009 – Correlagen recently expanded its CardioGeneScan test, the first comprehensive genetic test for the diagnosis of familial cardiac disease.

October 16, 2009 – AstraZeneca yesterday said the U.S. Food and Drug Administration cleared CRESTOR (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol.

October 16, 2009 – BIOTRONIK yesterday said it recently received the Industry’s first European CE Mark approval so BIOTRONIK Home Monitoring can replace in-hospital device follow-up visits.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now